Cancer Rop Co. Ltd. (180400) — Cash Flow Reinvestment Rate

Latest as of December 2022: 4.66x

Cancer Rop Co. Ltd. (180400) has a Cash Flow Reinvestment Rate of 4.66x as of December 2022, reinvesting ₩4.03 Billion (capex ₩1.74 Billion plus investments ₩2.30 Billion) from operating cash flow of ₩865.55 Million. See how much free cash does Cancer Rop Co. Ltd. generate to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

4.66x
(Capex + Investments) / Operating CF

Total Reinvested

₩4.03 Billion
Capex + Investments

Operating Cash Flow

₩865.55 Million
KRW

Capital Expenditures

₩1.74 Billion
KRW

Cancer Rop Co. Ltd. Cash Flow Reinvestment Rate (2014–2022)

Historical reinvestment intensity for Cancer Rop Co. Ltd. across 2 annual periods. For the full cash flow conversion analysis, see Cancer Rop Co. Ltd. (180400) cash flow conversion.

Annual Cash Flow Reinvestment Rate for Cancer Rop Co. Ltd. (2014–2022)

Year-by-year capital reinvestment analysis for Cancer Rop Co. Ltd.. See Cancer Rop Co. Ltd. free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2022 4.66x ₩4.03 Billion ₩865.55 Million ₩1.74 Billion ▲ +1015.3%
2014 0.42x ₩327.62 Million ₩783.83 Million ₩316.72 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow